Cargando…
African Swine Fever Virus (ASFV): Immunity and Vaccine Development
Autores principales: | Chathuranga, Kiramage, Lee, Jong-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967541/ https://www.ncbi.nlm.nih.gov/pubmed/36851077 http://dx.doi.org/10.3390/vaccines11020199 |
Ejemplares similares
-
Regulation of antiviral immune response by African swine fever virus (ASFV)
por: Zheng, Xiaojie, et al.
Publicado: (2022) -
A novel TLR3 inhibitor encoded by African swine fever virus (ASFV)
por: de Oliveira, V. L., et al.
Publicado: (2011) -
A Mathematical Model that Simulates Control Options for African Swine Fever Virus (ASFV)
por: Barongo, Mike B., et al.
Publicado: (2016) -
African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2′3′-cGAMP
por: Ranathunga, Lakmal, et al.
Publicado: (2023) -
The African Swine Fever Virus (ASFV) Topoisomerase II as a Target for Viral Prevention and Control
por: Coelho, João, et al.
Publicado: (2020)